Stay up to date on asthma and COPD treatment options
Why sign up?
- Stay up to date on treatment guidelines for asthma ad COPD
- Make use of easy patient education and support materials
- Get clinical trial and research results
- Learn the latest professional insights and opinions on asthma and COPD
- Read about patient experiences of asthma and COPD treatment
"These wehale.life contents helped me to improve my patients' knowledge about their pathology and treatment, thus improving adherence and disease control."
José Miguel Rodríguez González-Moro
Pulmologist, Hospital Príncipe de Asturias, Alcalá de Henares, Madrid
Register here for full access to wehale.life
Already registered? Log in here
We would like to process your contact details to allow us send you information about our product and services Orion Corporation delivers only information that we believe may be of value to you, relevant to your work and tailored to your professional role and interests. This information could be of a promotional or educational nature. You may withdraw your consent to direct marketing at any time by clicking through the link in any of the communications that you receive.
To tailor our communications, we may collect other information from you, and we may observe how you engage with Orion websites if you have consented to the use of cookies. Please read more about how we use your information and your rights from our Privacy Statement.
Choose the top three qualities for your ideal inhaler
Having just the right kind of inhaler can make a great difference in the treatment outcomes for asthma and COPD. What do you think are the essential qualities in an inhaler? Simplicity? Accuracy? Something elso entirely? Register for wehale.life - we will soon be in touch with a chance for you to define your preferred qualities for an inhaler.
Supporting you in the treatment of patients with asthma and COPD
Single-inhaler combination therapy in bronchial asthma – real-world data from daily clinical practice
Real-world studies can provide valuable information on patient experience and satisfaction with the inhaler, as well as on clinical efficacy and adherence to inhaled treatment in daily use. Read about the efficacy of combination therapy in bronchial asthma as evaluated in a Polish real-world study.
Ability of patients with asthma to achieve correct inspiratory flow rates for different inhalers
Consultant physician Doctor Omar Usmani, from Imperial College London and Royal Brompton Hospital, gave his expert insights on the correct inhalation technique for dry powder inhalers and metered dose inhalers, and shared the results of his recently published study' in a video interview.
The 2022 GINA Report: what’s new?
The GINA Scientific Committee has published an updated version of GINA global strategy for asthma management and prevention. What are the key changes in the report this year? Read and find out the new recommendations based on recent local clinical evidence.
Let's keep the planet breathing
Climate impact is becoming an increasingly important aspect for healthcare providers and patients alike when choosing therapy for asthma or COPD. See what Orion Pharma is doing to respond to this.
2021 Global strategy for prevention, diagnosis and management
GOLD has updated the recommendations on clinical management of chronic obstructive pulmonary disease. Read a summary of key changes in the 2021 strategy document here, along with the newest local recommendations.
Date of preparation: SEP 2022 / EASYH-2405
REGISTER TO LEARN MORE!
